Verkazia will offer treatment option for vernal keratoconjunctivitis
Ocular Surgery News | In June 2021, Verkazia was approved for the treatment of vernal keratoconjunctivitis in children and adults.OSN Pediatrics/Strabismus Board Members discussed the potential of Verkazia (cyclosporine ophthalmic emulsion 0.1%, Santen) and other treatments for vernal keratoconjunctivitis.
Source: healio.com